Results 91 to 100 of about 244 (122)

[Review of the interference between the most commonly prescribed drugs and clinical analyses at the Primary Health Care Centre of L'Hospitalet de Llobregat]. [PDF]

Aten Primaria, 2006
Vargas R, Torné N, Travé P, March M, Rodríguez G, Calero S.   +5 more
europepmc   +1 more source

Reposicionamento de fármacos com atividade sobre o efluxo e a formação de biofilmes em Staphylococcus epidermidis

Resumo A espécie Staphylococcus epidermidis é um importante agente patogénico nosocomial, geralmente associado a elevada resistência aos compostos antimicrobianos mediada por diversos mecanismos, incluindo o efluxo. Adicionalmente, a sua capacidade
NEVES, Joana Franco de Matos e Silva
core  

[Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine]. [PDF]

Aten Primaria, 2011
Belén Ferro-Rey M, Roca-Cusachs A, Sicras-Mainar A, Alvarez-Martín C, de Salas-Cansado M.   +4 more
europepmc   +1 more source

Metabolicheskie i organoprotektivnye effekty kombinatsii amlodipina i atorvastatina u bol'nykh s metabolicheskim sindromom

Systemic Hypertension, 2012
N V Blinova, M A Saidova, E V Tishina, I E Chazova   +3 more
openaire   +1 more source

Normal erythrocyte calpain I activity on membrane proteins under near-physiological conditions in patients with essential hypertension. [PDF]

Sao Paulo Med J, 2002
Dantas de Medeiros TM, Ortega KC, Mion D, Nonoyama K, Barretto OC.   +4 more
europepmc   +1 more source

Fiksirovannaya kombinatsiya amlodipina i valsartana: komu zhe ona neobkhodima v pervuyu ochered'?

Systemic Hypertension, 2008
openaire   +1 more source

Speckle-Tracking: Incremental Role in Diastolic Assessment of Pediatric Patients with Chronic Kidney Disease. [PDF]

Arq Bras Cardiol
Penachio FM, Diniz MFR, Laurino RSP, Watanabe A, Sawamura KSS, Lianza AC, Menezes CRB, Silva ISL, Leal GN.   +8 more
europepmc   +1 more source

Elektrokemijske metode za istovremeno određivanje amlodipina i drugih lijekova za terapiju hipertenzije i hiperlipidemije

Hipertenzija je najučestalija kardiovaskularna bolest i broj oboljelih od nje raste iz dana u dan. Za liječenje hipertenzije dostupan je velik broj lijekova različitih mehanizama djelovanja, koji se zbog prirode bolesti često kombiniraju. Lijek često zastupljen u tim kombinacijama je amlodipin, blokator kalcijevih kanala s posebnim značajkama koje ga ...
openaire   +1 more source

Komentarz. Połączenie telmisartan-amlodipina a najnowsze wytyczne leczenia hipotensyjnego 2017

Choroby Serca i Naczyń, 2017
openaire   +1 more source